These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3517481)

  • 21. [Genetic factors in ischemic heart disease].
    Slavchev S
    Vutr Boles; 1986; 25(3):12-9. PubMed ID: 3532554
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood coagulation disorders and their correction in periodontal disease].
    Ivanov VS; Belikov PP
    Stomatologiia (Mosk); 1985; 64(6):44-7. PubMed ID: 3866401
    [No Abstract]   [Full Text] [Related]  

  • 23. Vascular disease with cerebral effects in young identical twins.
    Bergin JD
    Proc Aust Assoc Neurol; 1968; 5(3):631-8. PubMed ID: 5709994
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrinolysis incidence in arteriosclerosis-induced illnesses as well as in arteriosclerosis positive and negative syntropic diseases].
    Schulz FH; Bach G; Künzel A
    Dtsch Gesundheitsw; 1970 Apr; 25(15):682-4. PubMed ID: 5483709
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of path analysis in coronary heart disease research.
    Rao DC; Province MA; Wette R; Glueck CJ
    Prog Clin Biol Res; 1984; 147():193-212. PubMed ID: 6610877
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary hyperlipemia: intra-platelet and serum NEFA. Their relation to hypercoagulability].
    Yañez-Polo MA; Muñoz-González J; C-Soriguer-Escofet F; Causse-Prado M; Lissen-Otero E; León-Castro J
    Minerva Med; 1974 Apr; 65(25):1329-39. PubMed ID: 4849473
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipemia--blood coagulation--atherosclerosis].
    Székely J; Gerö S
    Z Arztl Fortbild (Jena); 1966 Sep; 60(17):978-84. PubMed ID: 4870043
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin resistance in relation to hyperlipidemia and hypercoagulability in atherosclerotic diabetics and non-diabetics.
    Higazi AM; el-Ebrashy N; Aly AM; el-Din AS
    J Egypt Med Assoc; 1972; 55(8):577-94. PubMed ID: 4658037
    [No Abstract]   [Full Text] [Related]  

  • 29. [Disorders of lipid levels and metabolism as risk factors for the onset and development of cerebral arteriosclerosis and cerebral ischemia].
    Jovicić A; Veljancić D; Dordević D; Malicević Z
    Vojnosanit Pregl; 1996; 53(2):125-32. PubMed ID: 9214092
    [No Abstract]   [Full Text] [Related]  

  • 30. [The possible role of hereditary predisposition in the development of individual local manifestations of atherosclerosis of the nervous system].
    Davidenkova EF; Liberman IS
    Klin Med (Mosk); 1965 Sep; 43(9):7-11. PubMed ID: 5870055
    [No Abstract]   [Full Text] [Related]  

  • 31. [Risk factors for atherosclerosis in adolescents depending on their heredity].
    Metel'skaia VA; Andreenko GV; Belokon' NA; Aĭngorn ED; Leont'eva IV
    Klin Med (Mosk); 1988 Jun; 66(6):36-40. PubMed ID: 3184800
    [No Abstract]   [Full Text] [Related]  

  • 32. [Characteristics of changes in blood coagulability and fibrinolysis in acute myocardial infarct during the 1st hours of the diseases].
    Petrus' VG
    Vrach Delo; 1974 May; 5(0):52-4. PubMed ID: 4407763
    [No Abstract]   [Full Text] [Related]  

  • 33. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Idiopathic familial hyperlipoproteinemia].
    Madejska M; Nawrocka E
    Wiad Lek; 1972 May; 25(10):913-5. PubMed ID: 5029357
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic factors predisposing to the familial incidence of atherosclerosis.
    Válek J; Grafnetter D; Kohout M; Slabochová Z; Honzák R
    Rev Czech Med; 1976; 22(4):201-8. PubMed ID: 996302
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current tendency and trends in the delineation and definition of atherosclerosis].
    Velican C
    Stud Cercet Med Interna; 1973; 14(1):17-31. PubMed ID: 4619230
    [No Abstract]   [Full Text] [Related]  

  • 38. Autopsy findings in type 3 hyperlipoproteinemia.
    Holimon JL; Wasserman AJ
    Arch Pathol; 1971 Dec; 92(6):415-7. PubMed ID: 5121031
    [No Abstract]   [Full Text] [Related]  

  • 39. Dyslipoproteinemias in atherosclerosis, thrombosis and restenosis after coronary angioplasty.
    Myler RK; Ryan C; Dunlap R; Shaw RE; Bashour TT; Cumberland DC; Mooney MR
    J Invasive Cardiol; 1995 Mar; 7(2):33-46. PubMed ID: 10155712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-rheographic manifestations of cerebral arteriosclerosis in postinfarct cardiosclerosis].
    Slezkina LA
    Klin Med (Mosk); 1982 May; 60(5):97-100. PubMed ID: 7109524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.